SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-209924
Filing Date
2024-08-29
Accepted
2024-08-29 16:18:50
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d705006d10q.htm   iXBRL 10-Q 1799810
2 EX-31.1 d705006dex311.htm EX-31.1 9070
3 EX-31.2 d705006dex312.htm EX-31.2 9090
4 EX-32.1 d705006dex321.htm EX-32.1 5905
  Complete submission text file 0001193125-24-209924.txt   7370736

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ck0001817241-20240630.xsd EX-101.SCH 60382
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001817241-20240630_cal.xml EX-101.CAL 42072
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001817241-20240630_def.xml EX-101.DEF 305179
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001817241-20240630_lab.xml EX-101.LAB 442820
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001817241-20240630_pre.xml EX-101.PRE 384418
76 EXTRACTED XBRL INSTANCE DOCUMENT d705006d10q_htm.xml XML 1053166
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Filer) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42179 | Film No.: 241263980
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)